Demetriadou and colleagues show that downregulation of PRMT5 leads to activation of RBL2 and CDKN1A (p21Waf/Cip1) and repression of EIF4E and FGFR3 in CRC cells 36. Here, PRMT5 is linked to colorectal carcinoma.